The largest disparities were in the use of the new colorectal and lung cancer drugs: bevacizumab, cetuximab, erlotinib and pemetrexed, the study found.
2
英克隆将提留西妥昔单抗在美收入的39%，而百时美施贵宝将获得其余部分。
ImClone will keep 39 per cent of US revenues from Erbitux, with Bristol-Myers Squibb taking the rest.
3
目的探讨抗肿瘤靶向药物利妥昔单抗（美罗华）不良反应的特点及规律，为临床安全、合理用药提供参考。
Objective To investigate the adverse reactions of rituximab (Rituxan and MabThera) in retrospection to provide references for safe and rational drug use clinically.
点击反馈